The study identifies a novel transcription factor complex regulating IRF2BP2, but doesn't explain what molecular signals or conditions drive these three factors to specifically associate at this locus. This knowledge gap limits understanding of when and how this oncogenic program is activated in neuroblastoma development. Gap type: unexplained_observation Source paper: Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation. (2024, Neuro-oncology, PMID:38864832)
Landscape Summary: What determines the specificity of MYCN, MEIS2, and HAND2 complex formation at the IRF2BP2 super-enhancer? is a 0.76 priority gap in neuro-oncology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What determines the specificity of MYCN, MEIS2, and HAND2 complex formation at the IRF2BP2 super-enhancer? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: